Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MA, Alvarez Aldean J
Estimating the economically justifiable price of nirsevimab vs. Standard of Practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: A cost-utility modeling study
BMJ Public Health. 2025;3(2):e002441. doi: 10.1136/bmjph-2024-002441
Harper DM, Navarro-Alonso JA, Bosh FX, Paavonen J, Stanley M, Sasieni P, Yébenes M, Martínez-Martínez N, Rodríguez A, García A, Martín-Gómez L, Vallejo-Aparicio L, Carrión H, Ruiz García Y